You are here

VLA2001

Small biotech says its Covid-19 vaccine spurs more antibodies than AstraZeneca’s. Will supply deals come now?

Endpoints

Mon, 10/18/21 - 11:08 am

Valneva's not too late in COVID-19 as analysts eye $1.1B in 2022 vaccine sales

Fierce Pharma

Thu, 06/3/21 - 11:00 am

Valneva joins the phase 3 Covid-19 vaccine club

EP Vantage

Thu, 04/22/21 - 10:47 am

clinical trials

Valneva Initiates Phase 1/2 Clinical Study of Inactivated, Adjuvanted COVID-19 Vaccine Candidate

Drugs.com

Sun, 12/20/20 - 11:04 pm

clinical trials